Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Border

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathyT Yamamoto, T Nakamura, N A Noble, et al.
The Journal of Clinical Investigation|February 1, 1982
Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigenW A Border, H J Ward, E S Kamil, et al.
Archives of Pathology & Laboratory Medicine|April 1, 1982
Henoch-Schönlein purpura: simultaneous demonstration of IgA deposits in involved skin, intestine, and kidneyJ A Stevenson, L A Leong, A H Cohen, et al.
The American Journal of Pathology|June 1, 1988
Antigenic charge as a factor in resistance to immunosuppressive therapyS G Adler, H Y Wang, A H Cohen, et al.
The Journal of Biological Chemistry|June 5, 1992
The 260-kDa transforming growth factor (TGF)-beta binding protein in rat glomeruli is a complex comprised of 170- and 85-kDa TGF-beta binding proteinsK MacKay, D Danielpour, D Miller, et al.
Kidney International|February 1, 1990
Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathyG N Marinides, G C Groggel, A H Cohen, et al.
Kidney International|February 1, 1988
Changes in heparan sulfate correlate with increased glomerular permeabilityG C Groggel, J Stevenson, P Hovingh, et al.
Blood|January 1, 1981
Cell elastimetry in the detection of antineutrophil antibodiesM E Miller, L A Boxer, E J Kawaoka, et al.
Kidney International|March 1, 1992
Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosisW A Border, N A Noble, T Yamamoto, et al.
Nature|July 26, 1990
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1W A Border, S Okuda, L R Languino, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathyT Yamamoto, T Nakamura, N A Noble, et al.
The Journal of Clinical Investigation|February 1, 1982
Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigenW A Border, H J Ward, E S Kamil, et al.
Archives of Pathology & Laboratory Medicine|April 1, 1982
Henoch-Schönlein purpura: simultaneous demonstration of IgA deposits in involved skin, intestine, and kidneyJ A Stevenson, L A Leong, A H Cohen, et al.
The American Journal of Pathology|June 1, 1988
Antigenic charge as a factor in resistance to immunosuppressive therapyS G Adler, H Y Wang, A H Cohen, et al.
The Journal of Biological Chemistry|June 5, 1992
The 260-kDa transforming growth factor (TGF)-beta binding protein in rat glomeruli is a complex comprised of 170- and 85-kDa TGF-beta binding proteinsK MacKay, D Danielpour, D Miller, et al.
Kidney International|February 1, 1990
Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathyG N Marinides, G C Groggel, A H Cohen, et al.
Kidney International|February 1, 1988
Changes in heparan sulfate correlate with increased glomerular permeabilityG C Groggel, J Stevenson, P Hovingh, et al.
Blood|January 1, 1981
Cell elastimetry in the detection of antineutrophil antibodiesM E Miller, L A Boxer, E J Kawaoka, et al.
Kidney International|March 1, 1992
Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosisW A Border, N A Noble, T Yamamoto, et al.
Nature|July 26, 1990
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1W A Border, S Okuda, L R Languino, et al.
Pageof 11